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Reporting Summary
Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency 
in reporting. For further information on Nature Research policies, see Authors & Referees and the Editorial Policy Checklist.
Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main 
text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement
An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one- or two-sided 
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested
A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons
A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND 
variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Give P values as exact values whenever suitable.
For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings
For hierarchical and complex designs, identification of the appropriate level for tests and full reporting of outcomes
Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated
Clearly defined error bars 
State explicitly what error bars represent (e.g. SD, SE, CI)
Our web collection on statistics for biologists may be useful.
Software and code
Policy information about availability of computer code
Data collection Spectrum Mill v6.01 pre-release, NIS elements, CytExpert.
Data analysis Graphpad Prism 7, FlowJo, Microsoft Excel, R studio, MATLAB (version R2017b), FISH-QUANT, Cell Profiler (version 2.2.0 and version 
3.0.0),  BEDTools, Integrative Genomics Viewer (version 2.3.26), Igvtools 2.3, STAR v2.5.2a, TopHat version 2.0.8, MACS2, Picard's 
MarkDuplicates, Bowtie 2, DESeq2, SUPPA2, diffSplice, kallisto, Stringtie v1.3.3b, MAFFT.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers 
upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Data
Policy information about availability of data
All manuscripts must include a data availability statement. This statement should provide the following information, where applicable: 
- Accession codes, unique identifiers, or web links for publicly available datasets 
- A list of figures that have associated raw data 
- A description of any restrictions on data availability
Sequencing data associated with Fig. 2, 3, and Extended Data Fig. 3, 4, 5 is available at the Gene Expression Omnibus under the accession number GSE114953. 
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The original mass spectra associated with Fig. 1, 3, and Extended Data Fig. 4 may be downloaded from MassIVE (http://massive.ucsd.edu) using the identifier: 
MSV000012345. The data is directly accessible via ftp://massive.ucsd.edu/MSV000012345.
Field-specific reporting
Please select the best fit for your research. If you are not sure, read the appropriate sections before making your selection.
Life sciences Behavioural & social sciences  Ecological, evolutionary & environmental sciences
For a reference copy of the document with all sections, see nature.com/authors/policies/ReportingSummary-flat.pdf
Life sciences study design
All studies must disclose on these points even when the disclosure is negative.
Sample size No statistical measures were used to predetermine sample size. We typically performed at least 3 biological replicates for each experiment, 
unless otherwise noted in the figure legends. Quantitative mass spectrometry experiments using isobaric mass tag labeling include 2 replicate 
experiments in each 4plex or 6plex mass tag cassette as is common practice.
Data exclusions Mass spectrometry data were filtered for common laboratory contaminants. We further required a minimal number of unique peptides as 
defined in the Methods. Otherwise no data were excluded.
Replication As reported in the figure legends, main text and Methods, the findings were reliably reproduced.
Randomization This study uses a candidate-based approach to dissect molecular interactions and biochemical mechanisms. No randomization was required 
because the results of biochemical measurements or sequencing of nucleic acid libraries are not affected by sample randomization.
Blinding This study uses a candidate-based approach to dissect molecular interactions and biochemical mechanisms. No blinding was required because 
the results of biochemical measurements or sequencing of nucleic acid libraries are not affected by knowledge of sample identities. DNA 
combing was performed by scientists at specialized service facilities and sample identities were not disclosed to the person performing the 
experiment or data analysis.
Reporting for specific materials, systems and methods
Materials & experimental systems
n/a Involved in the study
Unique biological materials
Antibodies
Eukaryotic cell lines
Palaeontology
Animals and other organisms
Human research participants
Methods
n/a Involved in the study
ChIP-seq
Flow cytometry
MRI-based neuroimaging
Antibodies
Antibodies used RBMX – Cell Signaling (D7C2V) #14794, Lot #1, 2, (IP (6 ug/ml), western blot (1:1000), proximity ligation assay (1:250), 
immunofluorescence (1:250)) 
RBMX – Santa Cruz Biotechnology (G17) #sc-14581, Lot #K0614, (IP (6 ug/ml) and western blot (1:1000)) 
ALYREF – Bethyl #A302-892A, Lot #1, (IP (6 ug/ml)) 
ALYREF – Santa Cruz Biotechnology (11G5) #sc-32311, Lot # J1016, (western blot (1:1000)) 
PUM1 – Bethyl #A302-577A, Lot #1, (IP (6 ug/ml)) 
V5 – Abcam (SV5-Pk1) #ab27671, Lot #GR242588-4, (IP (6ug/ml)) 
V5 – Abcam #ab9116, Lot #GR256657-12, (western blot (1:1000)) 
Flag – Cell Signaling (9A3)  #8146S, Lot #3, (proximity ligation assay (1:250)) 
TOP1 – Bethyl #A302-589A, Lot #1, (IP (6 ug/ml), proximity ligation assay (1:250)) 
TOP1 – Bethyl #A302-590A, Lot #3, (western blot 1:1000) 
TOP1 – Santa Cruz Biotechnology (C-21) #sc-32736, Lot #K0515, (western blot (1:1000)) 
TOP1 – Thermo Fisher Scientific (24.5) #435900, Lot #QC215904, (proximity ligation assay (1:250)) 
CDC5L – Bethyl #A301-681A, Lot #1, (IP (6 ug/ml)) 
CDC5L – Santa Cruz Biotechnology (2136C1a) #sc-81220, Lot #C0917, (western blot (1:1000)) 
PRPF19 – Bethyl #A300-101A, Lot #1, (western blot (1:500)) 
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ACTB – Abcam #ab8226 (western blot (1:1000)) 
BRCA1 – Bethyl #A301-378A, Lot #2, (western blot (1:1000)) 
BRCA2 – Bethyl #A300-005A (western blot (1:1000)) 
Alpha-Tubulin−FITC – Sigma Aldrich #F2168 (immunofluorescence (1:1000)) 
Anti-Centromere antibodies (ACA) –  Antibodies Incorporated #15-234-0001 (immunofluorescence (1:200)) 
Normal Rabbit IgG - Cell signaling #2729, Lot #8, (IP (6 ug/ml) )
Validation All antibodies were validated by western blot. Commercial antibodies were also validated by the manufactures as indicated on 
their web sites.
Eukaryotic cell lines
Policy information about cell lines
Cell line source(s) HCT116 cell line was acquired from ATCC.
Authentication Cell lines were not authenticated.
Mycoplasma contamination Cell lines tested negative for mycoplasma.
Commonly misidentified lines
(See ICLAC register)
No commonly misidentified cell lines were used.
Flow Cytometry
Plots
Confirm that:
The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
Methodology
Sample preparation A detailed description of the sample preparation procedure is given in the 
Methods sections "Cell cycle analysis".
Instrument Beckman Coulter Cytoflex S
Software CytExpert, FlowJo.
Cell population abundance No post-sort fractions were collected.
Gating strategy Cell cycle analysis: We applied forward and side scatter parameters (FSC, SSC) to 
exclude cell debris and doublets as exemplified in Supplementary Figure 1. 
Typically, 3-4% of events were excluded to remove events that could not be 
assigned to cells in G1-, S-, and G2-M-phase. The fraction of cells in each phase of 
the cell cycle was then quantified using indicated gates (contour plot).
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
